AroCell Q4: Nearing positive operating cash flow
Research Update
2024-02-23
13:48
Redeye leaves its estimates and valuation untouched following the report. However, our gross margin assumptions might be reconsidered (downward) if the coming quarters do not show better gross margin development.
Oscar Bergman
Disclosures and disclaimers